Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory Activity-Reference-Cited by-同舟云学术

Synthesis of Novel Nitroxoline Analogs with Potent Cathepsin B Exopeptidase Inhibitory Activity

Published:2020-09-21 Issue:24 Volume:15 Page:2477-2490
ISSN:1860-7179
Container-title:ChemMedChem
language:en
Short-container-title:ChemMedChem

Author:

Van de Walle Tim¹^ORCID,Briand Marina¹,Mitrović Ana²,Sosič Izidor³,Gobec Stanislav³,Kos Janko²⁴,Persoons Leentje⁵,Daelemans Dirk⁵,De Jonghe Steven⁵,Ubiparip Zorica⁶,Desmet Tom⁶,Van Hecke Kristof⁷,Mangelinckx Sven¹,D'hooghe Matthias¹^ORCID

Affiliation:

1. SynbioC Research Group, Department of Green Chemistry and Technology Faculty of Bioscience Engineering Ghent University Coupure Links 653 9000 Ghent Belgium

2. Department of Biotechnology Jožef Stefan Institute Jamova 39 1000 Ljubljana Slovenia

3. Department of Pharmaceutical Chemistry Faculty of Pharmacy, University of Ljubljana Aškerčeva 7 1000 Ljubljana Slovenia

4. Department of Pharmaceutical Biology Faculty of Pharmacy, University of Ljubljana Aškerčeva 7 1000 Ljubljana Slovenia

5. Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation KU Leuven Herestraat 49 3000 Leuven Belgium

6. Centre for Synthetic Biology (CSB), Department of Biotechnology Faculty of Bioscience Engineering, Ghent University Coupure Links 653 9000 Ghent Belgium

7. Xstruct, Department of Chemistry Faculty of Sciences, Ghent University Krijgslaan 281-S3 9000 Ghent Belgium

Funder

Universiteit Gent

Javna Agencija za Raziskovalno Dejavnost RS

Hercules Foundation

Publisher

Wiley

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics,Molecular Medicine,Drug Discovery,Biochemistry,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cmdc.202000402

Reference52 articles.

1. WHO “Cancer ” can be found under https://www.who.int/news-room/fact-sheets/detail/cancer 2019.

2. Drug repurposing in cancer

3. Cancer statistics, 2019

4. Biologically Targeted Cancer Therapy and Marginal Benefits: Are We Making Too Much of Too Little or Are We Achieving Too Little by Giving Too Much?

5. Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells;Bioorganic & Medicinal Chemistry Letters;2023-01

2. A decennary update on diverse heterocycles and their intermediates as privileged scaffolds for cathepsin B inhibition;International Journal of Biological Macromolecules;2022-12

3. Chelation in Antibacterial Drugs: From Nitroxoline to Cefiderocol and Beyond;Antibiotics;2022-08-15

4. Behind every smile there's teeth: Cathepsin B's function in health and disease with a kidney view;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2022-04

5. Nitroxoline suppresses metastasis in bladder cancer via EGR1/circNDRG1/miR-520h/smad7/EMT signaling pathway;International Journal of Biological Sciences;2022